[An association between the FABP2 gene polymorphism and efficacy of valproates].

Autor: Aksenova MG, Burd SG, Kachalin EIu, Avakian GN, Badalian OL, Savenkov AA, Tertyshnik OIu, Dorofeeva MIu, Belousova ED, Gusev EI
Jazyk: ruština
Zdroj: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2007; Vol. 107 (1), pp. 42-5.
Abstrakt: To search for association between the 163G>A polymorphism of the fatty acid binding protein 2 (FABP2) gene and intracellular transport of the valproic acid in the small intestines, 168 patients with different forms of epilepsy, aged from 1 to 89 years, and different illness duration have been studied. The patients received valproates (127 patients) and topiramate (41 patients) as a monotherapy. It has been shown that the 163G>A (Ala54Thr) polymorphism exerts an influence on effective dose of the valproic acid but not of topiramate.
Databáze: MEDLINE